Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision v3.5.2 was added and the previous revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:31:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:52:43.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The version history now shows an addition of Revision: v3.4.3 and removal of Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:47:31.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Study Status updated to Completed on 2026-02-25 and Recruitment Status updated accordingly, replacing the previous Active, not recruiting status.
    Difference
    0.2%
    Check dated 2026-02-25T18:57:55.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    An administrative update adds Revision: v3.4.2 to the history and removes the earlier funding/operating-status notice, reflecting system maintenance rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:11:37.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Site-wide notice about government funding lapse was added, and the page revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T06:24:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.